Publicaciones en las que colabora con PATRICIA ASPICHUETA CELAÁ (98)

2024

  1. A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes

    Hepatology

  2. Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

    Hepatology

  3. Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway

    Cell Reports Medicine, Vol. 5, Núm. 7

  4. Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

    Liver International

  5. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  6. Protein kinase D2 modulates hepatic insulin sensitivity in male mice

    Molecular Metabolism, Vol. 90

  7. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

  8. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597

  9. Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells

    Liver International, Vol. 44, Núm. 1, pp. 125-138

2023

  1. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    NMR in Biomedicine, Vol. 36, Núm. 8

  2. Expanding the roles of the renin–angiotensin system: Drug-induced liver injury

    Journal of Hepatology

  3. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  4. In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 15-26

  5. In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 1-13

  6. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD

    Metabolism: Clinical and Experimental, Vol. 145

  7. miR-21p-5p coordinates biological pathways to promote MASLD progression

    Liver International

2022

  1. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

    Hepatology, Vol. 76, Núm. 6, pp. 1617-1633

  2. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

    Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 9, pp. 585-604

  3. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

  4. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24